November 21, 2012. The National Research Center for Women & Families supports the Data Act and shares concerns about the current and growing risk of antibacterial resistance to medically important drugs as a consequence of agricultural practices.
Read More »On Health Policy
Coalition Letter to U.S. Senators in Opposition of Efforts to Delay or Repeal Excise Tax on Medical Devices
December 19, 2012. As members of the Patient, Consumer, and Public Health Coalition, we strongly oppose efforts to delay or repeal the 2.3% excise tax on medical devices.
Read More »Testimony at FDA Public Hearing Establishing a List of Pathogens for the GAIN Act
December 18, 2012. Dr. Yttri testifies to the FDA that the growing risk of antibiotic resistant pathogens and need for development and responsible use of new antibiotics are critical public health concerns that need to be addressed.
Read More »Testimony at FDA Public Hearing on Antiseptic Preoperative Skin Preparation Products
December 10, 2012. Dr. Yttri testifies to the FDA on the serious public health issue of contamination of antiseptic products. There are several steps the FDA can take to better ensure the safety of consumers who are exposed to antiseptic preoperative skin preparation products.
Read More »Statement of Dr. Diana Zuckerman, Capitol Hill Press Conference for VALID Compounding Act
November 14, 2012. The VALID Compounding Act would save lives by closing loopholes in the law.
Read More »